Andlauer Healthcare Group (AND) related – Canada’s largest vaccine plant opens with two more on the way
Andlauer Healthcare Group (AND) related – Canada’s largest vaccine plant opens with two more on the way
Some news on the growing manufacturing capacity for vaccines in Canada, which I believe will be beneficial to Andlauer Healthcare Group (AND) given its dominant position in the transport and logistics of pharmaceuticals in Canada.
Last week, multinational pharmaceutical company Sanofi announced that it has opened the largest vaccine manufacturing facility in Canada at its Toronto campus. The new facility significantly increases manufacturing capacity to meet Canadian and global demand for pediatric and adult vaccines for whooping cough, diphtheria and tetanus. These vaccines will be exported to 60 markets globally.
Additionally, 1) Sanofi continues to work on opening a new manufacturing facility for flu vaccines – to be completed in 2026 and operational in 2027; and 2) Moderna completed the construction of its Québec manufacturing facility for mRNA respiratory vaccines in February 2024 with commercial production expected in 2025.
(Sources: Company Reports, Globe and Mail, Government of Canada)
Endri Leno, CFA
416-823-8125
https://www.linkedin.com/in/endri-leno-msc-mba-cfa/
Disclaimer & Disclosures
The views in these notes are the opinion of the writer, for informational purposes only and do not constitute financial, investment, or any other type of advice or any type of solicitation. All statements herein, other than statements of historical fact, are to be considered forward looking. Such forward-looking information and statements are based on my personal expectations, views, projections and/or publicly available information. Further, to the best of my knowledge, the information throughout these notes is current as of the date of transmission and based on sources believed to be accurate; although I make no representation as to the accuracy or completeness of the sources or these notes. All information in these notes is provided “as is” and I disclaim any duty to update any forward-looking expectations. All statements in these notes were independently developed by me and have not been endorsed, reviewed, influenced, etc. by anyone else. You may not disseminate or distribute any portion of these notes without my express written permission and they are intended to be read only in the jurisdictions where it is legally permissible to do so to conform local legal obligations. I expressly disclaim any liability for damages of any kind that may arise from or may be related to the view expressed in these notes.
The equities discussed are held by myself or members of my immediate family.